Teva Pharmaceutical Industries TEVA
NYSE TEVA
$41.25 -0.06 (-0.15%)
As of: Oct 20, 2026 · 1:21 PM EDT

Teva Pharmaceutical Industries (TEVA) Short-Term Debt repayments (2020 - 2023)

Updated

Teva Pharmaceutical Industries' Short-Term Debt repayments came in at $500 million for Q4 2023, up 150.0% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Short-Term Debt repayments (2020 - 2023) Analysis & Trends

For FY2023, Teva Pharmaceutical Industries' Short-Term Debt repayments was $700 million.

  • Short-Term Debt repayments carries a five-year compound annual growth rate of 21.9% (FY2018 to FY2023).
  • Going back by year, Short-Term Debt repayments was $700 million in FY2021 (+25.2%), $559 million in FY2020 (+11.4%) and $502 million in FY2019 (+93.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,154.54 Bn 1,123.13 Bn 19.71 Bn -
2 Johnson & Johnson 623.94 Bn 542.46 Bn 17.26 Bn 6.45 Bn
3 AbbVie 511.93 Bn 485.04 Bn 12.70 Bn -
4 Merck 365.40 Bn 319.78 Bn 12.21 Bn -
5 Novartis Ag 297.27 Bn 261.26 Bn 11.24 Bn -
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn -
7 Amgen 234.77 Bn 190.17 Bn 7.24 Bn -
8 Gilead Sciences 192.76 Bn 166.96 Bn 6.22 Bn -
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn -
10 Teva Pharmaceutical Industries 48.04 Bn 34.89 Bn 2.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 500.00 Mn
Sep 30, 2023 200.00 Mn
Dec 31, 2021 500.00 Mn
Dec 31, 2020 443.00 Mn
API Access

Teva Pharmaceutical Industries Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=TEVA&period=max&api_key=YOUR_API_KEY